echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > COVID-19 vaccine during pregnancy reduces risk of infant hospitalization

    COVID-19 vaccine during pregnancy reduces risk of infant hospitalization

    • Last Update: 2022-03-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Compiled and organized by Yimaitong, please do not reprint without authorization
    .

    Evidence, although limited, on the safety and efficacy of vaccination against COVID-19 during pregnancy has been increasing, suggesting that the benefits of vaccination against COVID-19 outweigh any known or potential risks of vaccination during pregnancy
    .

    Recent studies on COVID-19 vaccination during pregnancy suggest that Sars-Cov-2-specific antibodies may be transferred across the placenta, which may provide protection to the infant
    .

    However, there is currently no epidemiological evidence that maternal vaccination during pregnancy protects the baby
    .

    Newly published data from MMWR shows that babies of mothers who were vaccinated against COVID-19 during pregnancy were less likely to be hospitalized for COVID-19
    .

    Researchers from Vanderbilt University conducted a negative case-control study of 379 hospitalized infants under 6 months of age between July 2021 and January 2022 to evaluate pregnant women who completed 2 doses of COVID-19 during pregnancy.
    19 Effectiveness of primary mRNA vaccination for preventing hospitalization for COVID-19 in infants
    .

    The median age of the infants tested was 2 months, 21% had at least one underlying disease, 176 had COVID-19 (case group), and 84% had unvaccinated mothers; 203 did not have COVID-19.
    19 of the infants were the control group, with 22% of preterm infants in both groups
    .

    RESULTS: Completion of a 2-dose vaccination series during pregnancy was 61% (95% CI, 31%-78%) effective in preventing infant hospitalization for COVID-19
    .

    The efficacy of the two-dose series completed in the first trimester was 32% (95% CI, –43% to 68%), and the efficacy of the two-dose series completed in the second trimester was 80% (95% CI, 55%).
    %-91%)
    .

    Of the 43 infants (24%) admitted to the ICU, 25 (15%) were critically ill and receiving life support, including one receiving extracorporeal membrane oxygenation
    .

    Neither the infant nor the mother of the infant who died was vaccinated
    .

    Among infants admitted to the ICU, 88% of their mothers were not vaccinated
    .

    This real-world assessment of 20 pediatric hospitals in the United States during Delta and Omicron variant cycles showed that maternal completion of a 2-dose primary mRNA COVID-19 vaccination series during pregnancy was associated with a reduced risk of COVID-19 hospitalization in infants <6 months of age
    .

    The above findings continue to underscore the importance of vaccinating against COVID-19 during pregnancy, not only to protect pregnant women but also their babies from hospitalization due to COVID-19
    .

    COVID-19 during pregnancy is associated with severe illness and death, and pregnant women with COVID-19 are more likely to experience preterm birth, stillbirth and other pregnancy complications
    .

    Therefore, pregnant women are advised to be vaccinated against COVID-19
    .

    COVID-19 vaccination during pregnancy is safe and effective, and COVID-19 vaccination during pregnancy is associated with maternal antibodies detectable in delivery, breast milk, and infant serum, suggesting intramaternal antibody transfer
    .

    In conclusion, the completion of 2-dose primary mRNA COVID-19 vaccine series during pregnancy can reduce the risk of hospitalization associated with COVID-19 in infants <6 months of age, and the infant protection effect of maternal vaccination in late pregnancy is higher
    .

    The U.
    S.
    Centers for Disease Control and Prevention (CDC) recommends that women who are pregnant, breastfeeding, trying to conceive, or who may become pregnant in the future get the COVID-19 vaccine and stay up-to-date on COVID-19 vaccine updates
    .

    References: 1.
    COVID-19 vaccination during pregnancy lowers hospitalization risk for infants.
    ByKalie VanDewater.
    February 15, 2022.
    2.
    Halasa NB, Olson SM,et al.
    Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19 –Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022.
    MMWR Morb Mortal Wkly Rep.
    ePub: 15 February 2022.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.